Steve Pawsey
InvestorGrowth Partner at Advent Life Sciences
About
Dr Steve Pawsey is a pharmaceutical physician with over 30 years of drug development experience across pharma and biotech. He joined Advent as a Growth Partner in early 2026, having previously served as CMO of two Advent portfolio companies, including KaNDy Therapeutics, where he oversaw development of elinzanetant (Lynkuet) ahead of its acquisition by Bayer. He trained in medicine at the University of London, initially in anaesthesia and critical care, and is a Fellow of the Faculty of Pharmaceutical Medicine.
Invests in
Biotech
Colleagues at Advent Life Sciences
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Dominic Schmidt
General Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Gail Jermyn
Investor Relations Partner at Advent Life Sciences
Frequently asked questions
- Who is Steve Pawsey?
- Dr Steve Pawsey is a pharmaceutical physician with over 30 years of drug development experience across pharma and biotech. He joined Advent as a Growth Partner in early 2026, having previously served as CMO of two Advent portfolio companies, including KaNDy Therapeutics, where he oversaw development of elinzanetant (Lynkuet) ahead of its acquisition by Bayer. He trained in medicine at the University of London, initially in anaesthesia and critical care, and is a Fellow of the Faculty of Pharmaceutical Medicine.
- Where does Steve Pawsey work?
- Steve Pawsey is Growth Partner at Advent Life Sciences.
- What does Steve Pawsey invest in?
- Steve Pawsey invests in Biotech.